Approximately 80% of malignant CRCs in humans exhibit mutations in APC, KRAS and p53, part of the adenoma-carcinoma sequence that drives normal colonic epithelium to progress to adenomas and eventually to malignant carcinomas3. This evidence concerns the gene KRAS and adenoma.